819 related articles for article (PubMed ID: 10331742)
41. Examination of the oncogenic potential of a tumor-associated antigen, intestinal alkaline phosphatase, in HeLa x fibroblast cell hybrids.
Latham KM; Stanbridge EJ
Cancer Res; 1992 Feb; 52(3):616-22. PubMed ID: 1732049
[TBL] [Abstract][Full Text] [Related]
42. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
43. Implication of chromosome 11 in the suppression of neoplastic expression in human cell hybrids.
Srivatsan ES; Benedict WF; Stanbridge EJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6174-9. PubMed ID: 2877730
[TBL] [Abstract][Full Text] [Related]
44. Tumorigenicity and oncogene expression in pediatric cancers.
Pasquale SR; Jones GR; Doersen CJ; Weissman BE
Cancer Res; 1988 May; 48(10):2715-9. PubMed ID: 3359432
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of tumorigenicity of a murine squamous cell carcinoma (SCC) cell line by a putative tumor suppressor gene on human chromosome 7.
Zenklusen JC; Oshimura M; Barrett JC; Conti CJ
Oncogene; 1994 Oct; 9(10):2817-25. PubMed ID: 8084587
[TBL] [Abstract][Full Text] [Related]
46. Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene.
Donzelli M; Bernardi R; Negri C; Prosperi E; Padovan L; Lavialle C; Brison O; Scovassi AI
Oncogene; 1999 Jan; 18(2):439-48. PubMed ID: 9927200
[TBL] [Abstract][Full Text] [Related]
47. Chromosomal radiosensitivity during the G2 cell cycle period and cytopathology of human normal x tumor cell hybrids.
Sanford KK; Parshad R; Stanbridge EJ; Frost JK; Jones GM; Wilkinson JE; Tarone RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2045-9. PubMed ID: 3948180
[TBL] [Abstract][Full Text] [Related]
48. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
[TBL] [Abstract][Full Text] [Related]
49. Genetic alterations in human gastric cancer.
Hirohashi S; Sugimura T
Cancer Cells; 1991 Feb; 3(2):49-52. PubMed ID: 2029453
[TBL] [Abstract][Full Text] [Related]
50. PA-1, a human cell model for multistage carcinogenesis: oncogenes and other factors.
Tainsky MA; Krizman DB; Chiao PJ; Yim SO; Giovanella BC
Anticancer Res; 1988; 8(5A):899-913. PubMed ID: 3052262
[TBL] [Abstract][Full Text] [Related]
51. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
52. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma.
Pasic I; Shlien A; Durbin AD; Stavropoulos DJ; Baskin B; Ray PN; Novokmet A; Malkin D
Cancer Res; 2010 Jan; 70(1):160-71. PubMed ID: 20048075
[TBL] [Abstract][Full Text] [Related]
53. Highly frequent allelic loss of chromosome 6q16-23 in osteosarcoma: involvement of cyclin C in osteosarcoma.
Ohata N; Ito S; Yoshida A; Kunisada T; Numoto K; Jitsumori Y; Kanzaki H; Ozaki T; Shimizu K; Ouchida M
Int J Mol Med; 2006 Dec; 18(6):1153-8. PubMed ID: 17089020
[TBL] [Abstract][Full Text] [Related]
54. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
Schäfer R; Hoffmann H; Willecke K
Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
[TBL] [Abstract][Full Text] [Related]
55. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer.
Bièche I; Champème MH; Lidereau R
Cancer Res; 1994 Aug; 54(16):4274-6. PubMed ID: 7913873
[TBL] [Abstract][Full Text] [Related]
56. Suppression of tumorigenicity, but not invasion, in glioblastoma/HeLa cell hybrids.
Ess K; Chen H; Kier A; Brackenbury R
J Cell Physiol; 1995 Mar; 162(3):341-7. PubMed ID: 7860642
[TBL] [Abstract][Full Text] [Related]
57. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
58. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
59. Role of oncogenes and tumor suppressor genes in a multistep model of carcinogenesis.
Barrett JC; Oshimura M; Koi M
Symp Fundam Cancer Res; 1986; 39():45-56. PubMed ID: 3321309
[TBL] [Abstract][Full Text] [Related]
60. Molecular biology of brain tumors.
Wu JK; Naber SP
Neurosurg Clin N Am; 1994 Jan; 5(1):127-33. PubMed ID: 8124087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
